Quarter Comparison
Revenue
Operating Income
Income Statement
Balance Sheet
Operating metrics disclosed this quarter
Read from the filing itself — XBRL does not carry these, so no standard financial dataset has them.
FB102 Vitiligo Phase 1b Subjects Enrolled
43
The Company reported positive topline data from its Phase 1b trial for patients with vitiligo in July 2026. The Phase 1b vitiligo study was a double-blind, placebo-controlled trial that enrolled 43 subjects, randomized 3:1 (32 on FB102 and 11 on placebo).
Full-Time Employees
23
As of June 30, 2026, Forte had 23 full-time employees.